Assignee
CEVEC PHARMACEUTICALS GMBH
DE·7 granted patents·7 pending applications·17 citations·filing 2003–2024
Top patents by PatentIndex Score
14 records- 0188US9315773B2Method for the production of permanent human cell linesCEVEC PHARMACEUTICALS GMBH·Filed 2014·Granted Apr 19, 2016·10 cites·21 claims
- 0276US12060569B2Inducible AAV REP genesCEVEC PHARMACEUTICALS GMBH·Filed 2023·Granted Aug 13, 2024·0 cites·17 claims
- 0376US10081798B2O-glycan sialylated recombinant glycoproteins and cell lines for producing the sameCEVEC PHARMACEUTICALS GMBH·Filed 2015·Granted Sep 25, 2018·2 cites·8 claims
- 0475US2025011813A1Inducible AAV REP genesCEVEC PHARMACEUTICALS GMBH·Filed 2024·Application pending·0 cites
- 0570US7488749B2Therapy of diseases of the eye, the inner ear and the central nervous systemCEVEC PHARMACEUTICALS GMBH·Filed 2003·Granted Feb 10, 2009·5 cites·1 claims
- 0667US2025002923A1Use of constitutively active variants of growth factor receptors as selection markers for the generation of stable producer cell linesCEVEC PHARMACEUTICALS GMBH·Filed 2024·Application pending·0 cites
- 0764US2025163459A1Improved cell lines and methods for the production of adeno-associated vectorsCEVEC PHARMACEUTICALS GMBH·Filed 2023·Application pending·0 cites
- 0861US11685932B2Inducible AAV Rep genesCEVEC PHARMACEUTICALS GMBH·Filed 2018·Granted Jun 27, 2023·0 cites·10 claims
- 0958US10793839B2O-glycan sialylated recombinant glycoproteinsCEVEC PHARMACEUTICALS GMBH·Filed 2018·Granted Oct 6, 2020·0 cites·4 claims
- 1058US2024263148A1Method for the Production of AAVCEVEC PHARMACEUTICALS GMBH·Filed 2021·Application pending·0 cites
- 1152US12060561B2Use of constitutively active variants of growth factor receptors as selection markers for the generation of stable producer cell linesCEVEC PHARMACEUTICALS GMBH·Filed 2018·Granted Aug 13, 2024·0 cites·11 claims
- 1251US2025270516A1Producer Cell Having Low Levels of VA-RNACEVEC PHARMACEUTICALS GMBH·Filed 2021·Application pending·0 cites
- 1344US2015259387A1Production of a hcmv based vaccine in human amniocyte cell linesCEVEC PHARMACEUTICALS GMBH·Filed 2013·Application pending·0 cites
- 1436US2019367890A1Cell Line for Producing Recombinant Glycoproteins with Di-Antennary N-Glycans, Methods Using the Same, and Recombinant GlycoproteinsCEVEC PHARMACEUTICALS GMBH·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CEVEC PHARMACEUTICALS GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →